Skip to content
Press release Regulatory

Nanoform Finland Plc – Manager’s transactions – Albert Hæggström

Company release

Nanoform Finland Plc

March 6, 2024

08.30 Finnish time / 07.30 Swedish time

Nanoform Finland Plc – Manager’s transactions – Albert Hæggström

Helsinki, Finland Manager’s transaction related to Nanoform Finland Plc’s Member of the Board Albert Hæggström’s purchase of Nanoform Finland Plc shares:

Nanoform Finland plc – Managers’ transactions – Haeggström

____________________________________________

Person subject to the notification requirement

Name: Haeggström, Albert Alexander

Position: Chief Financial Officer

Issuer: Nanoform Finland plc

LEI: 743700JJO2NU8LBS1592

Notification type: INITIAL NOTIFICATION

Reference number: 743700JJO2NU8LBS1592_20240304132419_27

____________________________________________

Transaction date: 2024-03-01

Venue: FSME

Instrument type: SHARE

ISIN: FI4000330972

Nature of the transaction: ACQUISITION

Transaction details

(1): Volume: 2484 Unit price: 3.0185 EUR

Aggregated transactions

(1): Volume: 2484 Volume weighted average price: 3.0185 EUR

For further information, please contact:

Peter Hänninen

General Counsel

peter.hanninen@nanoform.com

+358 50 353 0408

For investor relations queries, please contact:

Henri von Haartman

Director of Investor Relations

hvh@nanoform.com

+46 7686 650 11

About Nanoform

Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners globally to provide hope for patients in developing new and improved medicines utilizing Nanoform’s platform technologies. The company focuses on reducing clinical attrition and on enhancing drug molecules’ performance through its nanoforming technologies and formulation services. Nanoform’s capabilities include GMP manufacturing, and its services span the small to large molecule development space with a focus on solving key issues in drug solubility and bioavailability and on enabling novel drug delivery applications. Nanoform’s shares are listed on the Premier-segment of Nasdaq First North Growth Market in Helsinki (ticker: NANOFH) and Stockholm (ticker: NANOFS). Certified Adviser: Danske Bank A/S, Finland Branch, +358 40 744 1900. For more information, please visit www.nanoform.com.